Stocks to buy for one year: Brokerages recommend buying 5 largecap and 1 midcap stocks for up to 24% upside
Stocks to buy for one year: The market momentum going ahead will be directed by the strength of India Inc. earnings.
Stocks to buy for one year: Indian equities in early trade on Tuesday staged a strong performance as global cues turned positive amid likely de-escalation in the Iran-Israel conflict and a sharp plunge in crude oil prices. However, as concerns resurfaced in the latter half following reports of a possible ceasefire violation by Iran, Nifty erased most of the early gains and ended at 25,044, up only 0.29 per cent.
Experts believe that going forward the sustainability of an uptrend will hinge on the strength of domestic earnings, with optimism surrounding the upcoming Q1 results supported by favourable domestic macroeconomics.
So as the market sentiment remains positive, a slew of brokerages have made fresh 'buy' calls on select stocks across healthcare, pharma and IT among other sectors.
Metropolis Healthcare share price target
Emkay Global has recommended a buy on the stock for a target of Rs 2,050. The suggested target implies an upside of 21 per cent from the last closing price of Rs 1,696 per share.
SBI Cards and Payment Services share price target
Emkay Global has suggested to buy the stock for a target of Rs 1,075. Considering the last closing price of Rs 983, the stock has an upside potential of over 9 per cent.
Coforge share price target
Choice Broking on Coforge has given a buy call for a target of Rs 2,153. The set target implies an upside of 16 per cent from the last close.
Coforge finds favor with Choice Broking as well, which has issued a Buy call with a target of Rs 2,153, suggesting an upside of 17% from its current market price of Rs 1,832.
L&T Finance share price target
Mirae Asset Sharekhan has suggested buying the scrip for a target of Rs 240. The new upgraded target implies a potential upside of 20 per cent from the last close.
Ajanta Pharma share price target
Choice Broking has recommended buying the pharma scrip for a target of Rs 3,180 per share. The suggested price target implies a potential upside of over 24 per cent from the last closing price.
Apollo Hospitals share price target
Choice Broking has given a target of Rs 8,000 onthe hospital major. The set target implies an upside of over 14 per cent from the last close.
Disclaimer
The above stock recommendations are picked from brokerage reports. Investors are required to carry out their due diligence based on their risk appetite and goals before making any such bets for investments.